Tuesday, 13 October 2015

Competition in Craft Beer Market Strengthens Marketing Strategies

Each beer admirer has an onelist interpretation when trying to detail craft beer and tales of discovery to share. Defining a true craft beer becomes more difficult with each beer brand offering something new. Going over-board many craft beer manufacturers are bringing consumers into their marketing sphere. Brewers making customers feel like they are naturally discovering their beer, is worth a toast. Craft beer is a billion-dollar business today where off -strategy sale and marketing was unwelcomed so far as a pint of Natural Beer (rated as world's worst beer by Refinedguy.com in 2013) So how do craft beer makers anticipating growth apply as well as execute compelling marketing strategy?

How effective business plans unfold without adulterating reliability and tarnishing customer relationship? Marketing for craft beer apes’ small business enterprise as well as retail marketing. Besides this there is a lot more fun when integrated with social media like Facebook, Twitter, Instagram and more into the mix! Several studies indicate that craft beer represents just close to 6% of the entire beer industry, but the market is continuously pouring on many beer lovers. Craft drinkers today keep a tab and follow their preferred market on media to know the beers they got to try! Such social media strategy and follow function has enabled craft beer bars to stay more competitive than their rivals.

Another factor that has guided several craft breweries like Meg Gill and Tony Yanow based in Los –Angeles is wholesale beer distributorship. Many parts of the United States were earlier not very receptive to this beer category. The competition between the small craft breweries have heated up, and what’s more important is how different brands are defining the drinking experience beyond the can or bottle. Hosting or attending beer events has helped producers expand their presence and grow their customer base. For the inside scoop on how healthy are craft beers, we picked the below chart. 

So why is there so much of hype for craft beer marketing? Many answer because the entire world has woken up to different flavors and savor in everything and beer forms an important part. In an interview to CNBC’s, Closing Bell Founder and Brewer at Boston Beer Jim Koch said when began brewing in his kitchen almost thirty-one years ago, many did not appreciate his idea. He added, but now Americans have started demanding both quality and taste in their beer. Several researches reveal that in America alone the number of craft beers have almost doubled in size (between 2014 – 2015). By the end of 2015, experts indicate that there would be new breweries opening up in the country every 10 or 12 hours. Industry growth is increasing in different countries such as America, Australia etc. and steaming from the blend of provenance including retail environment and effective business models. 

Furthermore, the continuous growth of independent breweries demonstrates that increasing industry opportunities and demand are widespread. So with competition in the sector growing the need for producers to be able to differentiate and brew world-class beer has become more important than ever. The growth is likely to accelerate through the progress of tax breaks for breweries in countries like Australia. Small businesses have now emerged as of the intense spots in both a country’s economy as well as culture. Craft brewers are fulfilling the demand of their local communities, brewing up fresh jobs and encouraging tourism. New craft brewers who match standards like high quality have been welcomed by customers across the world with open arms. 

There has been a significant growth in the session beer that has not only allowed the existing craft beer lovers to increase the volume but also keep the consumption level of alcohol static. Thus most brands are beginning to look like volume drivers. Eyeing the exponential growth in the craft beer market Allied Market Research, has published a market research report on Global Beer Market. The study confirms craft beer market has paved a path for the next generation brewers. 

So to keep the craft beer sales on the rise the marketing cliché has played a major role in getting the service or brands in front of buyers. Craft beer manufacturers today need more than a simple ho-hum branding or advertising campaign or a Twitter page followers. Today, brands need to stand out and a little secret to it is creativity. Craft beers are in the front lines of competing with each other for cross –drinkers. 

Thursday, 8 October 2015

Smart Pills transforming the Diagnostics and Healthcare Market

Smart pills are ingestible medical devices consisting of elements such as sensors, cameras, patches and trackers that help in better diagnostics and monitoring. These unique devices can be easily swallowed and offer a non-invasive thorough examination of the gastrointestinal (GI) tract. The smart pills also enables comprehensive health monitoring of various physiological metrics and measuring medication adherence in patients. The below demo clearly indicates how to use the device to monitor your daily medicine intake.

Smart pill technology has revolutionized the field of GI diagnosis. Smart pills are likely to replace conventional diagnostic techniques such as endoscopy and colonoscopy. Capsule endoscopy is regarded as a major technical innovation, influencing investigation and management of various small bowel diseases, esophageal disorders, colonic disorders etc. Capsule endoscopes are designed to provide complete examination of GIT including images of esophagus, stomach, small intestine and large intestine.. The capsule endoscopy segment is gaining a strong foothold in the smart pills market.

The capsule endoscopy is noninvasive and causes minimal discomfort. The magnification obtained, here is of the order 1:8, which is much higher as compared to the conventional endoscopy. Various capsule endoscopes available in the market include small bowel capsule, colon capsule and esophagus capsule endoscopes. Small bowel capsule is the most commonly used capsule endoscope in patients with acute gastrointestinal bleeding or to detect symptoms of active Crohn’s disease (CD).On the other hand, esophagus capsule endoscopes are used to diagnose esophagitis and Barrett’s esophagus. 

Companies today are focusing on exploring the field of gastroenterology. Recent studies by various researchers to develop products have enabled clinicians to obtain clearer & better images of the GI tract which offers new hope for gastrointestinal cancer detection Recently, researchers from Chinese University of Hong Kong, have developed an advanced endoscope known as ‘Tadpole Endoscope (TE), which mimics the movement of tadpoles’. TE is different from existing wireless capsule endoscopes since the presence of a soft tail enables it to be guided around the GI tract remotely by a clinician. This allows for better imaging of the stomach and thereby helping in the accurate location of problems.

Recently in 2014, Given Imaging Ltd, a pioneer of capsule endoscopy received FDA clearance for PillCam COLON. The device provides new modality to ensure clear visualization of the colon in patients following incomplete colonoscopy. According to some recent studies, incomplete colonoscopies occur in approximately 750,000 patients in the United States alone every year. The number is further higher in women due to an increase in past pelvic surgeries. There is a growing demand for such devices among patients having long case history of abdominal surgery or advanced stage of diverticular disease. This non-invasive test enabled by PillCam COLON allows more people to get screened for colorectal cancer, and gives a minimally invasive, radiation-free option. These devices in the market have revolutionized colorectal cancer diagnostics and screening market worldwide. The following infographics shows how the product PillCam COLON works. 

Another key application of smart pills is patient monitoring that includes monitoring of parameters such as pH, temperature, pressure and drug adherence in patients. According to the World Health Organization (WHO) estimate, over 50% of us fail to take medicines correctly, while over 50% of drugs are prescribed or sold inappropriately. This leads to disastrous consequences, resulting in significant complications and deterioration of patient health. The situation aggravates with ageing of patients, since they often require management of one or more chronic conditions with multiple medications. The trend may also cost healthcare providers millions every year. 

To deal with such non-adherence in patients due to various reasons, Proteus Digital Health, Inc. California-based Proteus Digital Health and Otsuka Pharmaceuticals have developed smart pill having an ingestible sensor. The digital pill is first of its kind to be approved by the U.S. Food and Drug Administration (FDA) as an aid to measure medication adherence.  The new drug application accepted by FDA was for an oral tablet that combines Otsuka’s branded antipsychotic Abilify (aripiprazole) with an embedded ingestible sensor device developed by Proteus Digital Health The ingestible device consists of minuscule sensors made of silicon along with metals-magnesium and copper, present in traces. The device gets powered on when the metals come in contact with stomach acids thereby triggering the sensor to generate signals that can be picked up by a disposable bandage-like patch worn by patient. The patch relays information to a mobile phone application. The following link shows how clinicians will use FDA approved digital pill to monitor patients and facilitate effective drug delivery among them. 

With the patient’s consent, the information can be assessed by caregivers and clinicians, thus helping individuals to develop and sustain healthy habits. Furthermore, it enables medical practitioners and doctors to offer more effective, data-driven health-care. The application can track the drug's effects - whether it's been prescribed at the right dosage, or if it simply isn't having any effect on the patient’s body..

The following tweets highlights the promising features of smart pills.
There are many research studies done by market research firms which tracks the current and future market trends along with offering an insight into the key drivers and growth opportunities of the market across major regions. As per a recent report by Allied Market Research, the smart pills technology market would reach $627.1 million, globally, by 2020, registering 21.2% CAGR during the forecast period 2015-2020.

In future, technological advancements to enhance the features of smart pills such as non-invasiveness, patient convenience and real time monitoring would drive their adoption rate in patient monitoring, diagnostic imaging and drug delivery.

Wednesday, 7 October 2015

Quantum Dots (QD) Market Revenue Will Reach $5.04 Billion, Globally, by 2020

According to a new research report published by Allied Market Research titled "Quantum Dot (QD) Market - Global Analysis, Growth, Trends, Opportunities, Size, Share and Forecast through 2020," the global quantum dots (QD) market accrued revenue of $316 million in 2013 and it is expected to grow to $5,040 million by 2020 at a CAGR of 29.9% during 2014-2020. However, the volume consumption will grow a much faster rate of 116.5% during the same period to reach 72 ton in 2020. The high volume-value growth gap will be resultant of faster price erosion during the analysis period. The decline in prices can be attributed to the refinement of manufacturing technologies & mass production processes and high volume demand.


The key drivers for the growth of the QD market are efficient conversion of solar energy into power, rising use volume driven display devices and utility in multiple applications. Additionally, this technology is more efficient than conventional technologies. From the competitive scenario, display and lighting equipment manufacturers are eager to bring out QD based products, which is currently the prime factor for quantum dot market growth. "The QD display market is set to grow exponentially as many companies such as Sony Corp., LG Display etc. are getting into alliance with QD technology providers to commercialize QD displays, especially TV sets," note analysts Shreyas Naidu and Priyanka Gotsurve. "The QD technology enhances the color display by at least 50% and it is also an energy efficient technology," analysts added.

To read more, get a sample copy or to purchase the complete report, visit: http://www.alliedmarketresearch.com/quantum-dots-market

However, some of factors such as high cost of technology and slow adoption due to extended research are currently serving as the restraints for the market growth. Although, mass manufacturing and bulk purchasing will quickly negate the cost constraints. The further penetration of the technology in newer applications such as security & defense, food, and packaging will provide the essential future growth thrust to the market.  Furthermore, future use of newer and cost effective materials will provide the QD market an added competitive edge over other competitive materials such as organic dyes.

To request or get free sample visit here:

Among geographic markets, North America has the highest revenue share due to early adoption. The region is expected to grow consistently and attain revenue of $1.92 billion by 2020. However, Asia-Pacific is expected to have the highest CAGR of 30.4% for the analysis period 2013-2020.

Monday, 5 October 2015

Enzymes Market is Expected to Reach $5.4 Billion, Worldwide, by 2020

According to a new report by Allied Market Research titled, "World Enzymes Market -Opportunity and Forecast, 2014-2020", world enzymes market is expected to register a CAGR of 7.8% during 2015-2020. The household care segment holds about 1/3rd of the overall market share in 2014, due to large consumption of varied enzymes in detergents industry.


Presently, enzymes are witnessing high demand in various industries such as biofuels, food & beverages and detergents. The growing popularity of enzymes for production of renewable fuels such as biodiesel, preference of enzymes for manufacturing mild detergents and rising adoption of enzymes in pharmaceutical formulations are the key factors fueling the market growth. In addition, growing use of feed enzymes in animal nutrition would further boost the market growth. However, high sensitivity of enzymes to temperature and pH and risk of contamination would limit the overall market growth.
To know more about the report, visit the website at https://www.alliedmarketresearch.com/enzymes-market
Carbohydrases enzymes segment held a dominant position in 2014 and would continue to lead over the forecast period. This is due to its wide range of applications in detergents and food & beverages industry for the degradation of carbohydrate rich compounds such as starch. However, polymerases & nucleases segment is projected to be the fastest growing segment owing to its growing utilization in biotechnology and pharmaceutical research. Based on reaction, Hydrolases enzyme segment dominated the market with around 77.9% market share in 2014. This is due to the large scale use of hydrolytic enzymes for the hydrolysis of carbohydrates and proteins. Based on source, microorganism derived enzymes was the leading revenue generating segment (due to its feasibility for large scale production and wide range of applications) in 2014, accounting for around 3/5th of the overall market.
Key findings of the study: 
  • Pharma & biotech application is projected to deliver fastest growth during the forecast period
  • Plant derived enzymes segment would witness fastest adoption during the forecast period
  • The Asia Pacific would exhibit fastest growth during the forecast period
North America dominated the global enzymes market in 2014, due to established industrial manufacturing base and large adoption of advanced enzymes such as immobilized enzymes in this region. Key players operating in this market are continuously focusing on strategies such as acquisition and product launch to increase their manufacturing capacity, expand their market presence and gain additional market share. Many companies are actively developing advanced enzymes such as immobilized enzymes to maintain the standards of end products. Key companies profiled in the report are Novozymes (Latest News), DuPont, F. Hoffmann-La Roche AG, BASF, Life technologies, Advance enzyme Technologies Ltd, Affymetrix Inc., and Codexis Inc.

Deep Joshi
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Int'l: +1 (503) 505-6949
Toll Free: + 1-800-792-5285 (U.S. & Canada)
E-mail: sales@alliedmarketresearch.com

mHealth Market to Grow at an Impressive CAGR of 33.5% During 2015 - 2020

A new report by Allied Market Research, titled, "Global mHealth Market (Device, Service, Application, Stakeholders and Geography) - Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2014-2020", stated that the global mHealth market was valued at $10.5 billion in 2014 and is expected to grow at a CAGR of 33.5% during 2015-2020. Blood pressure monitors hold the largest share in the global mHealth device market followed by blood glucose monitors and cardiac monitors. Geographically,North America will continue to retain its leading position in the overall mHealth market throughout the analysis period.

Mobile health provides health service and information through mobile communication devices to address the health priorities and concerns. The advanced mobile and wireless technologies have transformed the face of healthcare services across the globe and are rendering the growth of mHealth market. Moreover, the continued growth in coverage of mobile cellular networks, rapid advances in mobile technologies & applications, increasing lifestyle diseases and growing awareness among patient population in emerging economies, are some of the key factors fostering the growth of global mHealth market. On contrary, the lower accuracy of devices, technology infancy in middle and lower income economies, weak reimbursement coverage, uncertainty in government regulations in certain regions, and low adoption among ageing population is hampering the market growth to certain extent.

To request more information about the report, visit the website at https://www.alliedmarketresearch.com/mhealth-2015-market

The major chunk of mHealth devices market - i.e. ~71% - is collectively commanded by BP monitors, blood glucose monitors and cardiac monitors. The large share of these monitors can be attributed to increased affordability of mobile compatible devices, integration of innovative technologies in monitoring devices and the increasing lifestyle disease such as diabetes, stroke, COPD, ischemic heart to name a few. Within mHealth services, diagnostic, monitoring and treatment services collectively hold about 74% of the market. The rapid growth of mHealth services market is attributed to rising government initiatives, increasing mHealth awareness programs in underdeveloped regions etc.
View the mHealth market forecast 2012 - 2020 at https://www.alliedmarketresearch.com/mobile-health-market
Key finding of the study 
  • Blood glucose meters is projected to be the fastest growing segment in global mHealth devices market registering a CAGR of 41% during the forecast period
  • United States continues to be the leading market in the North America mHealth market throughout the forecast period
  • Asia-Pacific is projected to be the fastest growing mHealth market registering a CAGR of 35.9% during 2015-2020
  • United Kingdome, France and Germany collectively accounts to 45% share in the Europe mHealth device market in 2014
  • Cardiovascular and diabetes mHelath application market remains the lucrative market segment for manufacturers
Geographically, North America and Europe constitute the two largest markets for mHealth and collectively accounted for 67% of the market revenue in 2014. They are expected to continue its hold on the global market throughout the forecast period. Early adoption of innovative technology, large patient population and high capacity to pay for services are some of the key factors responsible for the growth of mHealth market in these regions. However, the market outlook across developing economies is looking favorable and strong owing to the increasing awareness of chronic diseases, favorable government regulations and increased healthcare expenditure. Philips healthcare, Bayer Healthcare and Sanofi are some of the key companies enjoying a strong foothold in global mHealth market, especially in Asian countries. Key players profiled in this report include - Philips healthcare, Omron HealthCare Inc., Bayer Healthcare, LifeWatch, Cardionet Inc., Masimo Corporation, Sanofi, Boston Scientific, AT&T Inc., and Johnson & Johnson.

Deep Joshi
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Int'l: +1 (503) 505-6949
Toll Free: + 1-800-792-5285 (U.S. & Canada)
E-mail: sales@alliedmarketresearch.com

Monday, 17 August 2015

Health Experts Call For Funds To Boost Ebola Vaccine Shots

Last year, approximately 27,000 people were infected by the Ebola virus in West Africa. Several sources reveal that over 11,000 of them succumbed to the outbreak in 2014. The entire medical fraternity believes that effective Ebola vaccines would have saved many lives. However, the fact that the entire world now depends upon latest drugs or vaccine for the virus too cannot be ignored. This outbreak has affected mostly poor nations like Liberia, Leone and more. It was only after a public alarm; health officials from regions like Europe as well as United States paid a visit to West Africa. The sudden outbreak also persuaded scientists to develop and test potential vaccine candidates that had been awaiting consent for years. Several clinical trials in regions including Guinea too show that the latest inventions have proved fruitful.

 In addition, close to $ 8 billion was spent in Guinea, Liberia and Sierra Leone for the development of Ebola drugs and treatment reported ‘NY Times ‘.  The same source revealed that getting a vaccine costs anywhere between $500 million as well as $1 billion. These funds help several drug manufacturers or biotechnology firms and scientists that are working hard to produce vaccines but are deprived of resources to manufacture them or seek an approval. Moreover, with the ‘World Health Organization’ supporting clinical trials of the vaccine in areas including Guinea has acted as a boon for fund raising and has attracted contributions from several private companies and drug makers for new virus vaccine.

In July 2015, health experts from across the global seconded the need for creating a $2 billion Ebola virus vaccine production fund to boost new shots. Commenting on this the Welcome Trust’s director, Jeremy Farrar said "We can no longer sit back and ignore the chronic lack of progress in developing new vaccines, and improving existing ones." Jeremy was of the co – writers responsible for creating the fund. Allied Market Research has added a report titled “Global Potential Analysis of Ebola drug and Vaccines Market (Pipeline analysis, Drugs, Vaccines, and Geography) through 2020.” As per the report the vaccine manufacturing in regions such as Asia – Pacific, LAMEA, Europe and North America would observe tremendous growth.

Friday, 7 August 2015

Technology Trends Drives The Capsule Endoscopy System In 2015

Over the past few years medical sensors have become smaller. The MEMS (or Microelectrical-mechanical systems) have been popular in medical equipment, from stents to chemosensor. Even the capsule endoscopy systems comes with a miniature camera as well as radio technologies. These systems captures the images of human digestive tract from the inside. Latest discoveries in the data analytics, material science and equipment engineering collectively promise a much smaller and modish sensor. 

The recent development in miniaturization assures biocompatibility. Medical experts believe that the smaller the system, the less likely it would interfere with the immune mechanism. This is true for capsule endoscopy used to take images of the entire gastrointestinal tract. PillCam® SB launched by Covidien boasts of vitamin –sized, wireless pill design that can improve the diagnosis for small bowel diseases. Recently, a Vanderbilt University engineer, Pietro Valdastri received $1.5 million as grant to continue the development of his a unique magnetic capsule for patients with IBD.  

Besides this, miniaturization when combined with the latest electrochemical as well as optical techniques boosts specificity & sensitivity for several medical conditions or uses. For example, scientists indicate that when size of the capsule endoscopy system is reduced it allows medical professional pick up the elements on the device. The Qatar International Medical Congress held between May 26 – 28, 2015 also included video capsule endoscopy as well as many sensitive, yet important, next generation concepts on palliative care.

Apart from this, boom in data analytics have also observed some of the greatest advancements in the medical sensors industry. Medical experts now combine the sensor data with improved analytics as well as machine learning techniques to diagnose diseases accurately. Allied Market Research has published a report titled “World Capsule Endoscopy System - Market Opportunities and Forecast, 2014 – 2020.” As per the report the capsule endoscopy system would register a CAGR of 14.8 percent during the forecast period of 2014 to 2020 worldwide. The aforementioned report also uncovers there would a significant development of the capsule endoscopy system in regions such as North America, LAMEA, Asia Pacific and Europe.